Qi Wei

USPTO Granted Patents = 20 (Patent Applications = 3)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 16(Granted Patents)

Company Filing History:

13 out of 5,444

University of Texas System

patents

10 out of 16

Joyant Pharmaceuticals, Inc.

patents

9 out of 12

Immunesensor Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12311030 - Antibody-sting agonist conjugates and their use in immunotherapy (2025-05-27),

2. 12281078 - Quinoline cGAS antagonist compounds (2025-04-21),

3. 12134609 - Quinoline cGAS antagonist compounds (2024-11-05),

4. 12091387 - Quinoline cGAS antagonist compounds (2024-09-17),

5. 11873291 - Quinoline cGAS antagonist compounds (2024-01-16),

6. 11299512 - Cyclic di-nucleotide compounds and methods of use (2022-04-12),

7. 11213592 - Antibody-sting agonist conjugates and their use in immunotherapy (2022-01-04),

8. 11033635 - Antibody-STING agonist conjugates and their use in immunotherapy (2021-06-15),

9. 10829427 - Naphthoquinones, pro-drugs, and methods of use thereof (2020-11-10),

10. 10519188 - Cyclic di-nucleotide compounds and methods of use (2019-12-31),

11. 8846734 - Diazonamide analogs (2014-09-30),

12. 8592469 - Diazonamide analogs (2013-11-26),

13. 8476256 - Diazonamide analogs (2013-07-02),

14. 8334311 - Indoline anti-cancer agents (2012-12-18),

15. 8299268 - Methods for preparing diazonamides (2012-10-30),

Title: **Innovative Contributions of Qi Wei in Medical Therapy**

Introduction

Qi Wei is a notable inventor based in Dallas, Texas, recognized for his significant contributions to the field of medical therapy through his innovative research. With a remarkable portfolio of 19 patents, Qi Wei has demonstrated a commitment to advancing medical science, particularly in the development of novel compounds that target critical pathways in human health.

Latest Patents

Among his latest patents, Qi Wei has developed Quinoline cGAS antagonist compounds. This disclosure details compounds that act as cGAS antagonists, along with methods for their preparation, pharmaceutical compositions that include these compounds, and their potential applications in medical therapy. His work in this area is paving the way for new therapeutic strategies that could impact various diseases.

Career Highlights

Qi Wei has had an illustrious career, with pivotal roles at renowned institutions such as the Massachusetts Institute of Technology and Joyant Pharmaceuticals, Inc. His experience in these esteemed organizations has allowed him to refine his skills in research and development, further propelling his innovative endeavors.

Collaborations

Throughout his career, Qi Wei has collaborated with several esteemed colleagues, including Ming Zhou and Charles G Caldwell. These partnerships have fostered a collaborative environment for creativity and innovation, enhancing the quality and impact of their work in the realm of medical therapy.

Conclusion

In conclusion, Qi Wei's work exemplifies the spirit of innovation in the medical field. His patents not only illustrate his contributions as an inventor but also highlight the potential impact that his research could have on future therapeutic options. With a strong foundation of collaboration and a commitment to advancing healthcare, Qi Wei continues to be a significant figure in the landscape of medical inventions.

This text is generated by artificial intelligence and may not be accurate.